Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
OtherAccelerated Communication

Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors

Karla B. Mihalak, F. Ivy Carroll and Charles W. Luetje
Molecular Pharmacology September 2006, 70 (3) 801-805; DOI: https://doi.org/10.1124/mol.106.025130
Karla B. Mihalak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Ivy Carroll
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles W. Luetje
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 70 no. 3 801-805
DOI 
https://doi.org/10.1124/mol.106.025130
PubMed 
16766716

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received April 4, 2006
  • Accepted June 9, 2006
  • Published online August 21, 2006.

Article Versions

  • Earlier version (June 9, 2006 - 11:42).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Karla B. Mihalak,
  2. F. Ivy Carroll and
  3. Charles W. Luetje
  1. Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, Florida (K.B.M., C.W.L.); and Organic and Medicinal Chemistry, Research Triangle Institute, Research Triangle Park, North Carolina (F.I.C.)
  1. Address correspondence to:
    Dr. Charles W. Luetje, Department of Molecular and Cellular Pharmacology (R-189), University of Miami Miller School of Medicine, PO Box 016189, Miami, FL 33101. E-mail: cluetje{at}med.miami.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: June 2006 to March 2023

AbstractFullPdf
Jun 20061030363
Jul 2006360317
Aug 200610844277
Sep 20067890124
Oct 200610199129
Nov 20069310099
Dec 2006362548
Jan 2007693160
Feb 2007495055
Mar 2007465545
Apr 2007783142
May 2007193836
Jun 2007353944
Jul 2007463145
Aug 2007392635
Sep 2007189169
Oct 2007269977
Nov 20072310695
Dec 2007259067
Jan 20083712387
Feb 2008608062
Mar 2008609774
Apr 20083410476
May 20089210458
Jun 2008246853
Jul 2008274637
Aug 2008698180
Sep 2008225250
Oct 2008433845
Nov 2008325648
Dec 2008204139
Jan 2009354832
Feb 2009365248
Mar 2009493537
Apr 2009385255
May 2009363747
Jun 2009202025
Jul 2009293736
Aug 2009262841
Sep 2009313541
Oct 2009463341
Nov 2009482829
Dec 2009351218
Jan 2010372626
Feb 2010273562
Mar 2010424034
Apr 2010467542
May 2010375028
Jun 2010263026
Jul 2010183524
Aug 2010296235
Sep 2010414233
Oct 2010477345
Nov 2010325132
Dec 2010364426
Jan 2011535144
Feb 2011565741
Mar 2011506651
Apr 2011515439
May 2011425534
Jun 2011273626
Jul 2011424937
Aug 2011373935
Sep 2011646550
Oct 2011706257
Nov 2011728339
Dec 2011425135
Jan 2012504831
Feb 2012416544
Mar 2012437036
Apr 2012529155
May 2012433736
Jun 2012377440
Jul 2012557135
Aug 2012787256
Sep 2012346429
Oct 2012596636
Nov 2012494740
Dec 2012215624
Jan 2013597144
Feb 20134720060
Mar 2013559839
Apr 2013768660
May 2013566138
Jun 2013382917
Jul 2013313231
Aug 201325325
Sep 2013642825
Oct 2013624741
Nov 2013566938
Dec 2013428810
Jan 20146857925
Feb 20146457142
Mar 20146665228
Apr 20149315027
May 2014536929
Jun 2014303210
Jul 2014345220
Aug 2014477222
Sep 2014546629
Oct 2014747934
Nov 2014364717
Dec 201420489
Jan 2015263320
Feb 2015323921
Mar 2015335922
Apr 2015456238
May 2015215215
Jun 2015323616
Jul 2015395728
Aug 2015325926
Sep 2015395915
Oct 2015406219
Nov 2015377529
Dec 2015324914
Jan 2016546815
Feb 2016425533
Mar 2016456828
Apr 2016445813
May 2016385924
Jun 2016294523
Jul 2016435834
Aug 2016706938
Sep 2016334417
Oct 2016275928
Nov 2016236018
Dec 2016276533
Jan 201714487
Feb 2017136116
Mar 201786612
Apr 2017234415
May 2017193724
Jun 201710259
Jul 201719379
Aug 201711338
Sep 2017274518
Oct 2017216919
Nov 20172712120
Dec 20179488
Jan 2018177512
Feb 201894621
Mar 2018118823
Apr 201837738
May 201885215
Jun 2018124112
Jul 201834953
Aug 2018074103
Sep 201806862
Oct 201817039
Nov 201809124
Dec 20181992226
Jan 20193144119
Feb 201969932
Mar 2019561320
Apr 2019531013
May 20192858
Jun 201957211
Jul 201952715
Aug 201941710
Sep 201978817
Oct 20191891614
Nov 20196674
Dec 20196253
Jan 202045112
Feb 20204634
Mar 20205589
Apr 20207276
May 202055135
Jun 202050146
Jul 20205976
Aug 20203426
Sep 20204438
Oct 202055711
Nov 202065116
Dec 202010882
Jan 2021188266
Feb 202157226
Mar 2021501912
Apr 202161128
May 202139175
Jun 202149171
Jul 202144102
Aug 202137127
Sep 20213385
Oct 20218696
Nov 20214855
Dec 202156117
Jan 20228164
Feb 20225353
Mar 2022502610
Apr 202261108
May 202273145
Jun 20226961
Jul 20223797
Aug 20224653
Sep 202263168
Oct 202285166
Nov 20228524
Dec 202252124
Jan 2023711810
Feb 202368115
Mar 20235062

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 70 (3)
Molecular Pharmacology
Vol. 70, Issue 3
1 Sep 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherAccelerated Communication

Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors

Karla B. Mihalak, F. Ivy Carroll and Charles W. Luetje
Molecular Pharmacology September 1, 2006, 70 (3) 801-805; DOI: https://doi.org/10.1124/mol.106.025130

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherAccelerated Communication

Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors

Karla B. Mihalak, F. Ivy Carroll and Charles W. Luetje
Molecular Pharmacology September 1, 2006, 70 (3) 801-805; DOI: https://doi.org/10.1124/mol.106.025130
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • GABAA Receptor Desensitization by Low GABA
  • Structure of the Diltiazem Receptor Site on Calcium Channels
  • 5-HT and Sleep
Show more Accelerated Communications

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics